TYL
VENTE TOTALE: 9 250 titres (~3 448 279,75 $ US)
- Insiders
- MOORE H LYNN JR
- Total bought
- —
- Total sold
- $3,448,280
- Last activity
- 2026-08-28
- Last synced
-
2026-09-03 09:53:14
Insider holdings as a share of total assets aren't available for this company.
Price (1 year)
Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.
Market snapshot
Signal
Neutral signal Scored 2026-09-02
TYL exhibits solid financial health with strong deleveraging, expanding margins, and a net cash position (liquidity score 80, fundamentals trend 75), providing a sound long-term foundation.
The first sentence of the analysis written for TYL on 2026-09-02 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 44.0% | 41.0% | 40.3% | 39.0% | 41.8% | |
| Ebit Margin | 16.9% | 14.7% | 11.4% | 11.7% | 11.4% | |
| Ebitda Margin | 23.3% | 21.8% | 20.1% | 21.0% | 20.6% | |
| Operating Profit Margin | 15.3% | 14.0% | 11.2% | 11.7% | 12.9% | |
| Pretax Profit Margin | 16.7% | 14.4% | 10.2% | 10.1% | 10.0% | |
| Continuous Operations Profit Margin | 13.5% | 12.3% | 8.5% | 8.9% | 10.1% | |
| Net Profit Margin | 13.5% | 12.3% | 8.5% | 8.9% | 10.1% | |
| Bottom Line Profit Margin | 13.5% | 12.3% | 8.5% | 8.9% | 10.1% | |
| Current Ratio | 1.050 | 1.352 | 0.860 | 0.952 | 1.163 | |
| Quick Ratio | 1.050 | 1.352 | 0.860 | 0.952 | 1.163 | |
| Solvency Ratio | 0.239 | 0.232 | 0.194 | 0.163 | 0.128 | |
| Cash Ratio | 0.578 | 0.699 | 0.165 | 0.195 | 0.373 | |
| Price To Earnings Ratio | 62.015 | 93.459 | 105.853 | 81.623 | 136.190 | |
| Price To Earnings Growth Ratio | 3.327 | 1.663 | 0.000 | 0.000 | -7.209 | |
| Forward Price To Earnings Growth Ratio | 3.327 | 1.663 | 0.000 | 0.000 | -7.209 | |
| Price To Earnings Diluted Ratio | 63.049 | 95.312 | 107.763 | 83.310 | 140.825 | |
| Price To Earnings Diluted Growth Ratio | 3.317 | 1.704 | 417.042 | 63.649 | -7.592 | |
| Price To Book Ratio | 5.283 | 7.252 | 5.981 | 5.104 | 9.455 | |
| Price To Sales Ratio | 8.388 | 11.494 | 9.003 | 7.239 | 13.800 | |
| Price To Free Cash Flow Ratio | 30.686 | 40.674 | 53.663 | 40.429 | 69.508 | |
| Price To Operating Cash Flow Ratio | 29.934 | 39.337 | 46.186 | 35.113 | 59.110 | |
| Debt To Assets Ratio | 0.120 | 0.123 | 0.149 | 0.223 | 0.293 | |
| Debt To Equity Ratio | 0.183 | 0.188 | 0.237 | 0.399 | 0.597 | |
| Debt To Capital Ratio | 0.154 | 0.159 | 0.192 | 0.285 | 0.374 | |
| Long Term Debt To Capital Ratio | 0.009 | 0.150 | 0.169 | 0.267 | 0.361 | |
| Financial Leverage Ratio | 1.523 | 1.529 | 1.592 | 1.786 | 2.036 | |
| Working Capital Turnover Ratio | 10.062 | 18.224 | -21.330 | 40.058 | 4.658 | |
| Operating Cash Flow Ratio | 0.372 | 0.586 | 0.380 | 0.429 | 0.448 | |
| Operating Cash Flow Sales Ratio | 0.280 | 0.292 | 0.195 | 0.206 | 0.233 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.975 | 0.967 | 0.861 | 0.869 | 0.850 | |
| Debt Service Coverage Ratio | 0.763 | 27.053 | 4.907 | 6.246 | 6.203 | |
| Interest Coverage Ratio | 71.607 | 50.502 | 9.249 | 7.620 | 8.835 | |
| Short Term Operating Cash Flow Coverage Ratio | 1.073 | 64.776 | 7.639 | 12.715 | 12.392 | |
| Operating Cash Flow Coverage Ratio | 0.967 | 0.978 | 0.546 | 0.365 | 0.268 | |
| Capital Expenditure Coverage Ratio | 40.808 | 30.418 | 7.177 | 7.606 | 6.685 | |
| Dividend Paid And Capex Coverage Ratio | 40.808 | 30.418 | 7.177 | 7.606 | 6.685 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 35.391 | 52.447 | 46.105 | 36.768 | 70.259 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 44.0% | ▲3.1% | ▲2.8% |
| Ebit Margin | 17.0% | ▲2.3% | ▲3.7% |
| Ebitda Margin | 23.3% | ▲1.5% | ▲1.9% |
| Operating Profit Margin | 15.3% | ▲1.3% | ▲2.3% |
| Pretax Profit Margin | 16.7% | ▲2.3% | ▲4.5% |
| Continuous Operations Profit Margin | 13.5% | ▲1.2% | ▲2.9% |
| Net Profit Margin | 13.5% | ▲1.2% | ▲2.9% |
| Bottom Line Profit Margin | 13.5% | ▲1.2% | ▲2.9% |
| Current Ratio | 1.050 | ▼-0.302 | ▼-0.025 |
| Quick Ratio | 1.050 | ▼-0.302 | ▼-0.025 |
| Solvency Ratio | 0.239 | ▲0.007 | ▲0.048 |
| Cash Ratio | 0.578 | ▼-0.120 | ▲0.176 |
| Price To Earnings Ratio | 62.015 | ▼-31.444 | ▼-33.813 |
| Price To Earnings Growth Ratio | 3.327 | ▲1.664 | ▲3.771 |
| Forward Price To Earnings Growth Ratio | 3.327 | ▲1.664 | ▲3.771 |
| Price To Earnings Diluted Ratio | 63.049 | ▼-32.264 | ▼-35.003 |
| Price To Earnings Diluted Growth Ratio | 3.317 | ▲1.613 | ▼-92.307 |
| Price To Book Ratio | 5.283 | ▼-1.968 | ▼-1.332 |
| Price To Sales Ratio | 8.388 | ▼-3.106 | ▼-1.597 |
| Price To Free Cash Flow Ratio | 30.686 | ▼-9.989 | ▼-16.306 |
| Price To Operating Cash Flow Ratio | 29.934 | ▼-9.403 | ▼-12.002 |
| Debt To Assets Ratio | 0.120 | ▼-0.003 | ▼-0.062 |
| Debt To Equity Ratio | 0.183 | ▼-0.006 | ▼-0.138 |
| Debt To Capital Ratio | 0.154 | ▼-0.004 | ▼-0.078 |
| Long Term Debt To Capital Ratio | 0.009 | ▼-0.141 | ▼-0.182 |
| Financial Leverage Ratio | 1.523 | ▼-0.006 | ▼-0.170 |
| Working Capital Turnover Ratio | 10.062 | ▼-8.162 | ▼-0.273 |
| Operating Cash Flow Ratio | 0.372 | ▼-0.214 | ▼-0.071 |
| Operating Cash Flow Sales Ratio | 0.280 | ▼-0.012 | ▲0.039 |
| Free Cash Flow Operating Cash Flow Ratio | 0.976 | ▲0.008 | ▲0.071 |
| Debt Service Coverage Ratio | 0.763 | ▼-26.291 | ▼-8.272 |
| Interest Coverage Ratio | 71.607 | ▲21.105 | ▲42.044 |
| Short Term Operating Cash Flow Coverage Ratio | 1.073 | ▼-63.703 | ▼-18.646 |
| Operating Cash Flow Coverage Ratio | 0.967 | ▼-0.012 | ▲0.342 |
| Capital Expenditure Coverage Ratio | 40.808 | ▲10.390 | ▲22.269 |
| Dividend Paid And Capex Coverage Ratio | 40.808 | ▲10.390 | ▲22.269 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 35.391 | ▼-17.056 | ▼-12.803 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $19.56B | $24.57B | $17.57B | $13.39B | $21.97B | |
| Enterprise value | $19.22B | $24.46B | $18.10B | $14.27B | $23.05B | |
| EV / Sales | 8.24x | 11.44x | 9.28x | 7.71x | 14.48x | |
| EV / Op. cash flow | 29.41x | 39.17x | 47.58x | 37.40x | 62.01x | |
| EV / Free cash flow | 30.15x | 40.50x | 55.29x | 43.06x | 72.92x | |
| EV / EBITDA | 35.39x | 52.45x | 46.10x | 36.77x | 70.26x | |
| Net debt / EBITDA | -0.62x | -0.23x | 1.35x | 2.25x | 3.29x | |
| Current ratio | 1.05x | 1.35x | 0.86x | 0.95x | 1.16x | |
| Income quality | 2.07x | 2.38x | 2.29x | 2.32x | 2.30x | |
| Graham number | $119 | $105 | $79 | $75 | $71 | |
| Graham net-net | -$8 | -$13 | -$26 | -$34 | -$40 | |
| Tax burden | 80.9% | 85.4% | 83.7% | 87.6% | 101.6% | |
| Interest burden | 98.7% | 98.1% | 89.3% | 86.9% | 87.2% | |
| Working capital | $88.4M | $375.2M | -$140.6M | -$42.5M | $134.8M | |
| Invested capital | $3.72B | $4.01B | $3.60B | $3.72B | $3.80B | |
| Return on assets | 5.6% | 5.1% | 3.5% | 3.5% | 3.4% | |
| Operating ROA | 6.6% | 6.1% | 4.7% | 4.6% | 5.6% | |
| Return on tangible assets | 14.3% | 15.1% | 14.4% | 14.3% | 12.5% | |
| Return on equity | 8.5% | 7.8% | 5.6% | 6.3% | 6.9% | |
| Return on invested capital | 6.4% | 6.2% | 4.9% | 4.9% | 5.2% | |
| Return on capital employed | 9.2% | 7.3% | 5.9% | 5.7% | 5.3% | |
| Earnings yield | 1.6% | 1.1% | 0.9% | 1.2% | 0.7% | |
| Free cash flow yield | 3.3% | 2.5% | 1.9% | 2.5% | 1.4% | |
| Capex / Op. cash flow | 2.5% | 3.3% | 13.9% | 13.1% | 15.0% | |
| Capex / Depreciation | 10.8% | 13.5% | 31.0% | 31.5% | 41.0% | |
| Capex / Sales | 0.7% | 1.0% | 2.7% | 2.7% | 3.5% | |
| SG&A / Sales | 19.9% | 21.5% | 23.5% | 21.7% | 23.0% | |
| R&D / Sales | 8.8% | 5.5% | 5.6% | 5.7% | 5.9% | |
| Stock comp / Sales | 6.5% | 5.7% | 5.6% | 5.6% | 6.6% | |
| Intangibles / Total assets | 61.0% | 66.4% | 75.4% | 75.5% | 72.7% | |
| Days sales outstanding | 104d | 102d | 116d | 114d | 124d | |
| Days payables outstanding | 102d | 45d | 46d | 34d | 47d | |
| Operating cycle | 104d | 102d | 116d | 114d | 124d | |
| Cash conversion cycle | 2d | 57d | 70d | 80d | 76d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-20.4%EV / Sales ▼-28.0%EV / EBITDA ▼-32.5%EV / Op. cash flow ▼-9.752Earnings yield ▲+0.005Graham number ▲+13.895
Profitability
Return on equity ▲+0.008Return on assets ▲+0.005Return on invested capital ▲+0.002Return on capital employed ▲+0.019Operating ROA ▲+0.005Income quality ▼-0.304Tax burden ▼-0.045
Efficiency
Days sales outstanding ▲+1.310Days payables outstanding ▲+56.813Operating cycle ▲+1.310Cash conversion cycle ▼-55.503Capex / Sales ▼-0.003R&D / Sales ▲+0.033
Balance-sheet strength
Current ratio ▼-0.302Net debt / EBITDA ▼-0.397Working capital ▼-286729000.000Invested capital ▼-286918000.000Intangibles / Total assets ▼-0.054
Change over 5 years
Valuation
Market cap ▼-11.0%EV / Sales ▼-43.1%EV / EBITDA ▼-49.6%EV / Op. cash flow ▼-32.598Earnings yield ▲+0.009Graham number ▲+47.854
Profitability
Return on equity ▲+0.016Return on assets ▲+0.022Return on invested capital ▲+0.012Return on capital employed ▲+0.039Operating ROA ▲+0.010Income quality ▼-0.232Tax burden ▼-0.207
Efficiency
Days sales outstanding ▼-19.915Days payables outstanding ▲+54.961Operating cycle ▼-19.915Cash conversion cycle ▼-74.876Capex / Sales ▼-0.028R&D / Sales ▲+0.029
Balance-sheet strength
Current ratio ▼-0.112Net debt / EBITDA ▼-3.913Working capital ▼-46387000.000Invested capital ▼-73201000.000Intangibles / Total assets ▼-0.117
Employee count
Peer market caps
Congressional trades
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-07-07 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-05-15 | Gilbert Cisneros | Sale | $1,001 - $15,000 |
| 2026-04-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-01-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-01-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2025-09-11 | Lisa McClain | Sale (Full) | $1,001 - $15,000 |
| 2025-09-05 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2025-08-07 | Valerie Hoyle | Purchase | $1,001 - $15,000 |
| 2025-08-04 | Ro Khanna | Purchase | $1,000 - $15,000 |
| 2025-06-06 | Valerie Hoyle | Purchase | $1,001 - $15,000 |
| 2023-10-02 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-08-29 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-04-10 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2023-03-14 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2023-01-09 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-12-06 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-11-03 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-09-08 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-06-17 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-05-23 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-05-10 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2022-04-13 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2022-04-11 | Ro Khanna | Sale | $15,001 - $50,000 |
| 2022-02-17 | Ro Khanna | Purchase | $15,001 - $50,000 |
| 2022-01-20 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2021-02-25 | Ro Khanna | Purchase | $1,001 - $15,000 |
Recent news
- 2026-09-02 Tyler Technologies CEO Sells $3.4M: Worrying or Routine? The transaction involved the exercise of 9,250 options at $205.66 per share and an immediate sale at $372.79 per share, totaling ~$3.4 million on Aug. 28, 2026. The traded volume was equal to 9% of the direct equity stake held before the filing, leaving the net common stock position unchanged.
- 2026-09-02 Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine BRENTWOOD, Tenn. & TYLER, Texas--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the new UT Tyler School of Medicine Building in Tyler – the first time patient services and physician training share a single hub in the region. The building now houses UT Health East Texas women''s health, pulmonary, orthope.
- 2026-09-02 BP names Ian Tyler as new chair Oil major BP announces Ian Tyler will become its next chair, taking the position immediately.
- 2026-09-02 BP Appoints Interim Chairman Ian Tyler to Permanent Role Tyler joined the board as a nonexecutive director in April 2025 and was appointed interim chairman in May after BP removed Albert Manifold , citing “serious concerns” about governance and conduct.
- 2026-09-02 BP appoints Ian Tyler as permanent chair after interim stint BP PLC (LSE:BP.) has appointed Ian Tyler as chair with immediate effect, making permanent the role he has held on an interim basis since May.
- 2026-09-02 BP appoints Ian Tyler as chair after ousting Manifold over governance, conduct concerns BP has appointed Ian Tyler, former CEO of building group Balfour Beatty , as its permanent chairman, it said on Wednesday, having fired Albert Manifold in May after less than a year in the position, citing governance and conduct concerns.
- 2026-09-01 First American Title President Sally French Tyler Named a HousingWire Vanguard Award Winner for the Second Time SANTA ANA, Calif.--(BUSINESS WIRE)--First American Financial Corporation (NYSE: FAF), a premier provider of title, settlement, and risk solutions for real estate transactions and the leader in the digital transformation of its industry, today announced that Sally French Tyler, president of First American Title Insurance Company, was named a winner of HousingWire''s 2026 Vanguard Award. Tyler joins an exclusive group of two-time winners of the award, as she was previously recognized in 2024. The.
- 2026-09-01 Nebraska Expands Tyler Technologies'' AI Enabled Solutions Footprint Following Successful Pilot Program [url="]Tyler Technologies, Inc.[/url] (NYSE: TYL) today announced that the state of Nebraska has selected Tyler''s [url="]Resident AI Assistant[/url] for statewi
- 2026-09-01 Nebraska Expands Tyler Technologies'' AI Enabled Solutions Footprint Following Successful Pilot Program PLANO, Texas--(BUSINESS WIRE)---- $TYL #TylerTech--Tyler''s Resident AI Assistant goes statewide in Nebraska after a successful DMV pilot.
- 2026-08-28 Tyler Technologies (TYL) Up 14.4% Since Last Earnings Report: Can It Continue? Tyler Technologies (TYL) reported earnings 30 days ago. What''s next for the stock?